Copyright
©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 97007
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97007
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97007
Types | Origin | Markers | Role in TME |
MyCAFs | Pancreatic cells, PSCs | α-SMA, FAP, SMA, PDGFβ | Facilitate tumor cell invasion, migration, drug resistance[23-27] |
ICAFs | Bone marrow-originated monocytes | IL-6, IL-1β | Promote tumor inflammation, immune evasion, tumor progression[25,26,33,34] |
ApCAFs | Mesenchymal cells | MHC-II, RORγt | Enhance tumor aggression, amplify immune checkpoint inhibitor efficacy[25,35,36] |
- Citation: Hu ZY, Ding D, Song Y, Deng YF, Zhang CM, Yu T. Molecular mechanism of pancreatic ductal adenocarcinoma: The heterogeneity of cancer-associated fibroblasts and key signaling pathways. World J Clin Oncol 2025; 16(2): 97007
- URL: https://www.wjgnet.com/2218-4333/full/v16/i2/97007.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i2.97007